Supernus Pharmaceuticals
SUPN
SUPN
312 hedge funds and large institutions have $2.34B invested in Supernus Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 106 increasing their positions, 115 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.45% more ownership
Funds ownership: 96.94% → 99.38% (+2.4%)
8% less repeat investments, than reductions
Existing positions increased: 106 | Existing positions reduced: 115
32% less call options, than puts
Call options by funds: $5.1M | Put options by funds: $7.53M
Holders
312
Holding in Top 10
5
Calls
$5.1M
Puts
$7.53M
Top Buyers
| 1 | +$24.7M | |
| 2 | +$24.4M | |
| 3 | +$13.2M | |
| 4 |
Renaissance Technologies
New York
|
+$12.7M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.3M |
Top Sellers
| 1 | -$22M | |
| 2 | -$19.1M | |
| 3 | -$18.2M | |
| 4 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$13.5M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$6.4M |